Differential PI 3-kinase dependence of early and late phases of recycling of the internalized AT1 angiotensin receptor L Hunyady, AJ Baukal, Z Gáborik, JA Olivares-Reyes, M Bor, M Szaszák, ... Journal of Cell Biology 157 (7), 1211-1222, 2002 | 210 | 2002 |
β-arrestin-and dynamin-dependent endocytosis of the AT1 angiotensin receptor Z Gáborik, M Szaszák, L Szidonya, B Balla, S Paku, KJ Catt, AJL Clark, ... Molecular Pharmacology 59 (2), 239-247, 2001 | 151 | 2001 |
Mechanisms and functions of AT1 angiotensin receptor internalization L Hunyady, KJ Catt, AJL Clark, Z Gáborik Regulatory peptides 91 (1-3), 29-44, 2000 | 143 | 2000 |
The Role of a Conserved Region of the Second Intracellular Loop in AT1 Angiotensin Receptor Activation and Signaling Z Gáborik, G Jagadeesh, M Zhang, A Spät, KJ Catt, L Hunyady Endocrinology 144 (6), 2220-2228, 2003 | 142 | 2003 |
Intracellular trafficking of hormone receptors Z Gáborik, L Hunyady Trends in endocrinology & metabolism 15 (6), 286-293, 2004 | 117 | 2004 |
Differential β-arrestin binding of AT1 and AT2 angiotensin receptors G Turu, L Szidonya, Z Gáborik, L Buday, A Spät, AJL Clark, L Hunyady FEBS letters 580 (1), 41-45, 2006 | 86 | 2006 |
Sec14 homology domain targets p50RhoGAP to endosomes and provides a link between Rab and Rho GTPases G Sirokmány, L Szidonya, K Káldi, Z Gáborik, E Ligeti, M Geiszt Journal of Biological Chemistry 281 (9), 6096-6105, 2006 | 76 | 2006 |
Dependence of AT1 angiotensin receptor function on adjacent asparagine residues in the seventh transmembrane helix L Hunyady, H Ji, G Jagadeesh, M Zhang, Z Gáborik, B Mihalik, KJ Catt Molecular pharmacology 54 (2), 427-434, 1998 | 60 | 1998 |
Lys 199 mutation of the human angiotensin type 1 receptor differentially affects the binding of surmountable and insurmountable non-peptide antagonists FLP Fierens, PML Vanderheyden, Z Gáborik, T Le Minh, JP De Backer, ... Journal of the Renin-Angiotensin-Aldosterone System 1 (3), 283-288, 2000 | 58 | 2000 |
A systematic in vitro investigation of the inhibitor preincubation effect on multiple classes of clinically relevant transporters P Tátrai, P Schweigler, B Poller, N Domange, R de Wilde, I Hanna, ... Drug Metabolism and Disposition 47 (7), 768-778, 2019 | 57 | 2019 |
Major glucuronide metabolites of testosterone are primarily transported by MRP2 and MRP3 in human liver, intestine and kidney CY Li, A Basit, A Gupta, Z Gáborik, E Kis, B Prasad The Journal of steroid biochemistry and molecular biology 191, 105350, 2019 | 55 | 2019 |
Quantitative investigation of irinotecan metabolism, transport, and gut microbiome activation MM Parvez, A Basit, PB Jariwala, Z Gáborik, E Kis, S Heyward, ... Drug Metabolism and Disposition 49 (8), 683-693, 2021 | 52 | 2021 |
Agonist-Induced Phosphorylation of the Endogenous AT1 Angiotensin Receptor in Bovine Adrenal Glomerulosa Cells RD Smith, AJ Baukal, A Zolyomi, Z Gaborik, L Hunyady, L Sun, M Zhang, ... Molecular Endocrinology 12 (5), 634-644, 1998 | 49 | 1998 |
Role of the proline-rich domain of dynamin-2 and its interactions with Src homology 3 domains during endocytosis of the AT1 angiotensin receptor M Szaszák, Z Gáborik, G Turu, PS McPherson, AJL Clark, KJ Catt, ... Journal of Biological Chemistry 277 (24), 21650-21656, 2002 | 43 | 2002 |
Requirement of membrane-proximal amino acids in the carboxyl-terminal tail for expression of the rat AT1a angiotensin receptor Z Gáborik, B Mihalik, S Jayadev, G Jagadeesh, KJ Catt, L Hunyady FEBS letters 428 (3), 147-151, 1998 | 43 | 1998 |
Structural determinants of agonist-induced signaling and regulation of the angiotensin AT1 receptor L Hunyady, Z Gáborik, BH Shah, G Jagadeesh, AJL Clark, KJ Catt Molecular and cellular endocrinology 217 (1-2), 89-100, 2004 | 24 | 2004 |
Interactions between maraviroc and the ABCB1, ABCG2, and ABCC2 transporters: an important role in transplacental pharmacokinetics L Tupova, M Ceckova, C Ambrus, A Sorf, Z Ptackova, Z Gaborik, F Staud Drug Metabolism and Disposition 47 (9), 954-960, 2019 | 18 | 2019 |
Organic Anion Transporting Polypeptide–Mediated Hepatic Uptake of Glucuronide Metabolites of Androgens CY Li, A Gupta, Z Gáborik, E Kis, B Prasad Molecular Pharmacology 98 (3), 234-242, 2020 | 17 | 2020 |
Membrane transporters in physiological barriers of pharmacological importance I Nagy, B Tóth, Z Gáborik, F Erdo, P Krajcsi Current pharmaceutical design 22 (35), 5347-5372, 2016 | 17 | 2016 |
Structural requirements for signalling and regulation of AT1-receptors L Hunyady, Z Gáborik, G Vauquelin, KJ Catt Journal of the Renin-Angiotensin-Aldosterone System 2 (1_suppl), S16-S23, 2001 | 17 | 2001 |